Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v1-EN
Language English English
Date Updated 2020-07-22 2020-07-14
Drug Identification Number 02162644 02162644
Brand name TORADOL IM TORADOL IM
Common or Proper name Toradol IM Toradol IM
Company Name ATNAHS PHARMA UK LIMITED ATNAHS PHARMA UK LIMITED
Ingredients KETOROLAC TROMETHAMINE KETOROLAC TROMETHAMINE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 mL ampoules (trays of 5) containing 10 mg/mL 1 mL ampoules (trays of 5) containing 10 mg/mL
ATC code M01AB M01AB
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2020-07-14 2020-07-14
Actual start date
Estimated end date 2020-07-20 2020-07-20
Actual end date 2020-07-21
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Please contact Methapharm Inc. at 1-800-287-7686, by email at sales@methapharm.com or fax 519-751-9149 for any specific questions. Please contact Methapharm Inc. at 1-800-287-7686, by email at sales@methapharm.com or fax 519-751-9149 for any specific questions.
Health Canada comments